Abstract
In this study the cytotoxic effects of high concentrations (⩾ 1 × 10 −6 M) of estradiol-17β (E 2), 2-/4-hydroxyestradiol-17β (2-/4-OHE 2) and 2-/3-/4-methoxyestradiol-17β (2-/3-/4-MeOE 2) were determined on dividing MCF-7 and HeLa cells. The 2-MeOE 2 metabolite followed by 2-OHE 2 and E 2 (in this order) proved to be extremely toxic to dividing MCF-7 and HeLa cells. The cytotoxic effect on these cells comprised uneven chromosome distribution. Indirect immunofluorescent studies, in which monoclonal anti-α-tubulin antibodies were used, showed that these compounds (2-MeOE 2 > 2-OHE 2 > E 2) at high concentrations caused abnormal and fragmented polar formations as well as disorientated microtubule arrangement in the dividing MCF-7 and HeLa cells. The 4-OHE 2 and 3-/4-MeOE 2 metabolites had little or no cytotoxic effects on dividing cells. The large number of abnormal metaphases seen in HeLa cells exposed to 2-MeOE 2 suggested that this metabolite may be the ultimate cytotoxic compound. The reduction in the number of HeLa cells with abnormal metaphase configurations after exposure to 2-OHE 2 plus quinalizarin (an inhibitor of catechol- O-methyltransferase) indicated that the production of 2-MeOE 2 is necessary for the formation of abnormal spindles in metaphase. Quinalizarin treatment in the presence of 2-MeOE 2 had no effect on the large number of abnormal metaphases. We therefore conclude that neither E 2 nor 2-OHE 2, but a high concentration of 2-MeOE 2 is responsible for abnormal spindle formation. In additional experiments the number of normal and abnormal dividing HeLa cells were greatly reduced when simultaneously exposed to E 2 and 2-/4-hydroxylase-inhibitor α-naphthoflavone.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.